Andrea Wang-Gillam

Dr. Wang-Gillam is a medical oncologist and physician-scientist focusing on clinical and translational research in pancreatic cancer. Her research passion is fueled by the fact that pancreatic cancer patients have a very low life expectancy due to a lack of early detection and effective treatments. One of Dr. Wang-Gillam's research interests is to translate preclinical discoveries into clinical settings by designing and conducting hypothesis-driven trials. Dr. Wang-Gillam is the principal investigator (PI) of multiple clinical trials in pancreatic cancers. In addition, her laboratory has been investigating the therapeutic potentials of various downstream effectors of the KRAS, the key oncogenic driver for pancreatic ductal adenocarcinoma.